Medication info
Glimepidide Tablets (Glimepiride)

Glimepidide Tablets (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Intro Biopharma Co., Ltd.
Appearance
Green oblong tablets
Packaging
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201901767 · Approved 2019.03.25 · Insurance code 052401260

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start at 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose monitoring and adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate ingestion of sugar. Despite successful initial management of hypoglycemia during treatment with sulfonylureas, hypoglycemia may recur. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose, if possible, every day. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may be increased. Appropriate caution should be exercised.

Ingredients

Manufacturer
Intro Biopharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to aid in blood sugar control for patients with type 2 diabetes. It is typically taken alone in conjunction with dietary and exercise therapy. If blood sugar control is insufficient with other oral hypoglycemic agents, it may be combined with insulin. Additionally, in cases where monotherapy with sulfonylureas or metformin is not effective enough, it is taken with metformin to manage blood sugar more effectively. This drug helps in diabetes management by improving blood sugar control.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start at 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose monitoring and adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate ingestion of sugar. Despite successful initial management of hypoglycemia during treatment with sulfonylureas, hypoglycemia may recur. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose, if possible, every day. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may be increased. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or those in a diabetic ketoacidosis or coma state. Additionally, individuals allergic to this medication, its components, sulfonylureas, or sulfonamides should avoid taking it. There is no experience in using this medication in patients with severe liver or kidney damage, so a switch to insulin therapy is recommended. Women who are pregnant or may become pregnant, as well as lactating women, should not take this medication. Patients with severe infections, those undergoing surgical procedures, or those with severe trauma may require insulin therapy, so caution is warranted. When experiencing gastrointestinal disorders such as diarrhea or vomiting, the risk of hypoglycemia may increase due to impaired food absorption. This medication contains lactose, so individuals with lactose intolerance or specific genetic metabolic disorders should not take it. In the first week of dosing, the risk of hypoglycemia is high, so blood sugar levels should be checked frequently, and careful monitoring is necessary. Special caution should be taken in the elderly, those with poor nutritional status or irregular meals, those who frequently consume alcohol, and those with diminished liver or kidney function. This medication can cause hypoglycemia, so if symptoms such as headache, severe hunger, vomiting, fatigue, confusion, drowsiness, or decreased consciousness occur, immediate action should be taken. Visual disturbances, gastrointestinal disorders, liver dysfunction, blood abnormalities, and allergic reactions may occur, so healthcare professionals should be informed of any symptoms. In the event of hypoglycemia, quick recovery can usually be achieved by consuming sugar, so it is advisable to always carry some sugar. When taking this medication, adherence to dietary and exercise regimens is crucial, and it is important to stick to the prescribed dosages. Taking this medication with other drugs may affect blood sugar control, so all concurrently taken medications should be disclosed to healthcare professionals. For pregnant or lactating women, switching to insulin therapy is considered safer. In cases of overdose, severe hypoglycemia may occur, necessitating immediate emergency treatment, and close monitoring in a hospital for at least 1-2 days thereafter is needed.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or initiative, depression, confusion, language disorders, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, mucocutaneous syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, indigestion, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. Doing so will help preserve the medication's effectiveness and safety for a longer period.

Appearance and packaging

Appearance

Green oblong tablets

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.